News | April 19, 2026
Takara Bio and Resistomap forge deal to speed up global fight against superbugs
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Move strengthens footprint in Western India and expands multi-specialty care network
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences
The company allocated €56 million to research and development for next-generation line solutions
The programme is being implemented in collaboration with Grow Well Foundation and is expected to expand in a phased manner
The investment case for health technology in India is frequently overstated in one direction and understated in another
Revvity is positioning its technologies as a connected engine for discovery
Muted movement reflects consolidation phase as investors await earnings triggers
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
Subscribe To Our Newsletter & Stay Updated
